Agneta Heierson
Corporate Officer/Principal chez INFANT BACTERIAL THERAPEUTICS AB
Profil
Agneta Heierson is currently the Vice President-Clinical Development at Infant Bacterial Therapeutics AB.
She previously worked as the Global VP-Research & Development Supply Chain at AstraZeneca AB.
Postes actifs de Agneta Heierson
Sociétés | Poste | Début |
---|---|---|
INFANT BACTERIAL THERAPEUTICS AB | Corporate Officer/Principal | - |
Anciens postes connus de Agneta Heierson
Sociétés | Poste | Fin |
---|---|---|
AstraZeneca AB
AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden. | Corporate Officer/Principal | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 1 |
---|---|
INFANT BACTERIAL THERAPEUTICS AB | Health Technology |
Entreprise privées | 1 |
---|---|
AstraZeneca AB
AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden. | Commercial Services |